Moreover, it has been shown that GLO-1 contributes to the maintenance of an immunosuppressive microenvironment through MG-H1-mediated upregulation of the immune checkpoint programmed death ligand 1 (PD-L1), thereby promoting cancer progression (39). This evidence concerns the gene GLO1 and cancer.